Vitamin D receptor polymorphism found to influence COVID-19 severity

FHS
May 7, 2024
9:15 am

Researchers compared SNPs in the vitamin D receptor (VDR) gene between mild and severe COVID-19 patients.

Delix plans further trials with neuroplastogen after positive Phase I data – Pharmaceutical Technology

DLX-001 is a neuroplastogen designed to promote neuroplasticity without giving rise to the deleterious attributes of first- and second-generation psychedelics. Credits: 15Studio/Shutterstock.com Delix Therapeutics is

July 15, 2024

Acrylic Window to the Brain; Chronic Fatigue Discovery; AI Spots Parkinson’s Risk

Neurosurgery patients who had a piece of their skull removed were fitted with a prosthesis embedded with an acrylic window so doctors could peer inside

September 20, 2023

Research suggests laminin could play role in slowing progression of breast tumors

Cells are capable of translating mechanical changes into biological responses. This process is known as mechanotransduction and plays a fundamental role in the progression of

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.